Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy
About half of advanced stage head and neck squamous cell carcinoma (HNSCC) patients can be cured by chemoradiotherapy. Patient outcome may be partially determined by the genetic alterations in HNSCC, rendering these alterations promising candidate prognostic factors and/or therapeutic targets. Howev...
Main Authors: | David M. Vossen, Caroline V.M. Verhagen, Martijn van der Heijden, Paul B.M. Essers, Harry Bartelink, Marcel Verheij, Lodewyk F.A. Wessels, Michiel W.M. van den Brekel, Conchita Vens |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/4/445 |
Similar Items
-
Chemoradiotherapy Combined with Brachytherapy for the Definitive Treatment of Esophageal Carcinoma
by: Julian Mangesius, et al.
Published: (2023-07-01) -
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
by: Magnus Nilsson, et al.
Published: (2022-07-01) -
A retrospective study comparing definitive chemoradiotherapy vs. chemoradiotherapy followed by surgery in T4 esophageal squamous cell carcinoma patients who were downstaged after neochemoradiotherapy
by: Tian Zhang, et al.
Published: (2022-08-01) -
Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma
by: Koichi Yagi, et al.
Published: (2021-07-01) -
Long-term results of definitive concurrent chemoradiotherapy using S-1 in the treatment of geriatric patients with esophageal cancer
by: Lv S, et al.
Published: (2016-09-01)